Serdan, Tamires Duarte Afonso
Cervantes, Heidi
Frank, Benjamin
Iragavarapu, Akhil Gargey https://orcid.org/0000-0002-0483-7639
Tian, Qiyu
Hope, Daniel
Choi, Chan Hee J.
Hoffmann, Anne https://orcid.org/0000-0003-3258-3397
Ghosh, Adhideb https://orcid.org/0000-0002-5160-4571
Wolfrum, Christian https://orcid.org/0000-0002-3862-6805
Greenblatt, Matthew B. https://orcid.org/0000-0001-9794-8532
Cohen, Paul https://orcid.org/0000-0002-2786-8585
Blüher, Matthias https://orcid.org/0000-0003-0208-2065
Aydin, Halil
Schwartz, Gary J. https://orcid.org/0000-0003-0446-5553
Shamsi, Farnaz https://orcid.org/0000-0003-3506-6950
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R03DK135786)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (K01DK125608)
American Heart Association (24CDA1271852)
G. Harold and Leila Y. Mathers Foundation
Article History
Received: 10 May 2025
Accepted: 25 February 2026
First Online: 25 March 2026
Competing interests
: F.S. is a scientific co-founder and serves on the advisory board of Noara Therapeutics. M.B. received honoraria as a consultant and speaker from Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Lilly, Novo Nordisk, Novartis, and Sanofi. The remaining authors declare no competing interests.